We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+7.75%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$219M
AUM Growth
+$15.6M
Cap. Flow
+$1.2M
Cap. Flow %
0.55%
Top 10 Hldgs %
24.85%
Holding
101
New
4
Increased
36
Reduced
31
Closed

Sector Composition

Rank Sector Weight
1 Technology 14.9%
2 Industrials 13.7%
3 Healthcare 12.56%
4 Financials 10.53%
5 Consumer Staples 10.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OIH icon
51
VanEck Oil Services ETF
OIH
$2.01B
$1.68M 0.77%
3,339
+209
+7% +$105K
IBB icon
52
iShares Biotechnology ETF
IBB
$9.52B
$1.52M 0.7%
12,499
+655
+6% +$77.1K
BBH icon
53
VanEck Biotech ETF
BBH
$405M
$1.52M 0.69%
11,178
-755
-6% -$98.2K
JNJ icon
54
Johnson & Johnson
JNJ
$617B
$1.29M 0.59%
9,355
IAU icon
55
iShares Gold Trust
IAU
$63.8B
$1.17M 0.54%
51,280
-825
-2% -$19.2K
GOOG icon
56
Alphabet (Google) Class C
GOOG
$4.08T
$1.16M 0.53%
19,380
T icon
57
AT&T
T
$159B
$1.13M 0.52%
44,610
-276
-0.6% -$6.76K
CVX icon
58
Chevron
CVX
$383B
$1.12M 0.51%
9,192
-680
-7% -$82.5K
CTAS icon
59
Cintas
CTAS
$82.8B
$1.09M 0.5%
22,120
JPM icon
60
JPMorgan Chase
JPM
$933B
$998K 0.46%
8,853
-670
-7% -$76.1K
AMJ
61
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$951K 0.43%
34,655
-5,995
-15% -$167K
PFE icon
62
Pfizer
PFE
$142B
$888K 0.41%
21,261
-2,716
-11% -$105K
DIS icon
63
Walt Disney
DIS
$167B
$861K 0.39%
7,371
-20
-0.3% -$2.23K
SYK icon
64
Stryker
SYK
$133B
$805K 0.37%
4,534
AOR icon
65
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.66B
$664K 0.3%
14,722
-900
-6% -$40.3K
DUK icon
66
Duke Energy
DUK
$98.4B
$628K 0.29%
7,859
IBM icon
67
IBM
IBM
$209B
$607K 0.28%
4,203
SYY icon
68
Sysco
SYY
$40.6B
$599K 0.27%
8,190
NEE icon
69
NextEra Energy
NEE
$183B
$598K 0.27%
14,280
BXP icon
70
Boston Properties
BXP
$11.4B
$596K 0.27%
4,850
ORCL icon
71
Oracle
ORCL
$367B
$596K 0.27%
11,564
+2,054
+22% +$99.8K
BA icon
72
Boeing
BA
$175B
$584K 0.27%
1,571
PAYX icon
73
Paychex
PAYX
$41.4B
$571K 0.26%
7,755
BMY icon
74
Bristol-Myers Squibb
BMY
$132B
$529K 0.24%
8,530
+600
+8% +$35.6K
VEU icon
75
Vanguard FTSE All-World ex-US ETF
VEU
$66.8B
$519K 0.24%
9,989

Similar funds

Boston Research & Management's Q3 2018 Portfolio in Review

As of Q3 2018, Boston Research & Management held 101 positions worth $219M, up 7.7% from $203M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q3 2018: portfolio turnover was 4%. Boston Research & Management opened 4 new positions and made no exits, leaving the 101-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Industrials and Healthcare.

  • Boston Research & Management's largest Q3 2018 buy was UnitedHealth: 818 shares worth $217K.
  • Boston Research & Management added most to iShares Core MSCI EAFE ETF in Q3 2018, an estimated $452K increase.
  • Boston Research & Management's biggest Q3 2018 reduction was JP Morgan Alerian MLP Index ETN 5/24/24, cutting an estimated $167K.
  • Boston Research & Management's ten largest holdings make up 25% of its $219M portfolio in Q3 2018.
  • Boston Research & Management opened 4 new positions and closed 0 in Q3 2018.
  • Boston Research & Management's portfolio value rose 7.7% quarter-over-quarter to $219M.

Based on Boston Research & Management's 13F filing for Q3 2018, filed 13 Nov 2018.